Skip to main content
HealthReportedLow
2.0

Adium launches Lilly obesity/diabetes drug in Costa Rica

Adium has introduced a Lilly-developed medication for obesity and diabetes in Costa Rica, available since September 4 as prefilled KwikPen pens. This marks a market expansion for the drug in Central America, though details on pricing, coverage, and patient access remain unclear. The launch could improve treatment options for chronic metabolic conditions in the region.

Delfino.crabout 10 hours agoCR, USCredibility 10%View source

Score Breakdown

Mosaic Score2.0
Model confidence0.5
Significance0.1
Source credibility0.1

Intelligence Tags

Locations

Costa Rica

Entities

country
Source

Related signals

8 found